NO20010552L - FremgangsmÕte for fremstilling av zofenopril kalsiumsalt - Google Patents

FremgangsmÕte for fremstilling av zofenopril kalsiumsalt

Info

Publication number
NO20010552L
NO20010552L NO20010552A NO20010552A NO20010552L NO 20010552 L NO20010552 L NO 20010552L NO 20010552 A NO20010552 A NO 20010552A NO 20010552 A NO20010552 A NO 20010552A NO 20010552 L NO20010552 L NO 20010552L
Authority
NO
Norway
Prior art keywords
zofenopril
salt
calcium salt
preparation
potassium salt
Prior art date
Application number
NO20010552A
Other languages
English (en)
Other versions
NO319773B1 (no
NO20010552D0 (no
Inventor
Giorgi Raffaello
Original Assignee
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Spa filed Critical Menarini Ricerche Spa
Publication of NO20010552L publication Critical patent/NO20010552L/no
Publication of NO20010552D0 publication Critical patent/NO20010552D0/no
Publication of NO319773B1 publication Critical patent/NO319773B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20010552A 1998-08-04 2001-02-01 Fremgangsmate for fremstilling av zofenopril kalsiumsalt NO319773B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI001833A IT1301993B1 (it) 1998-08-04 1998-08-04 Processo per la preparazione di zofenopril sale di calcio.
PCT/EP1999/005461 WO2000007984A1 (en) 1998-08-04 1999-07-30 A process for the preparation of zofenopril calcium salt

Publications (3)

Publication Number Publication Date
NO20010552L true NO20010552L (no) 2001-02-01
NO20010552D0 NO20010552D0 (no) 2001-02-01
NO319773B1 NO319773B1 (no) 2005-09-12

Family

ID=11380611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010552A NO319773B1 (no) 1998-08-04 2001-02-01 Fremgangsmate for fremstilling av zofenopril kalsiumsalt

Country Status (32)

Country Link
US (2) US6521760B1 (no)
EP (1) EP1102745B1 (no)
JP (1) JP2002522417A (no)
KR (1) KR100593428B1 (no)
CN (1) CN1146538C (no)
AT (1) ATE266635T1 (no)
AU (1) AU5372299A (no)
BG (1) BG65022B1 (no)
BR (1) BR9912842A (no)
CA (1) CA2339283C (no)
CU (1) CU23171A3 (no)
CZ (1) CZ301908B6 (no)
DE (1) DE69917282T2 (no)
DK (1) DK1102745T3 (no)
EA (1) EA003454B1 (no)
EE (1) EE04798B1 (no)
ES (1) ES2221417T3 (no)
HK (1) HK1039616B (no)
HR (1) HRP20010083B1 (no)
HU (1) HU227557B1 (no)
IL (1) IL141222A0 (no)
IT (1) IT1301993B1 (no)
NO (1) NO319773B1 (no)
PL (1) PL193828B1 (no)
PT (1) PT1102745E (no)
RS (1) RS49768B (no)
SI (1) SI1102745T1 (no)
SK (1) SK285527B6 (no)
TR (1) TR200100272T2 (no)
UA (1) UA65628C2 (no)
WO (1) WO2000007984A1 (no)
ZA (1) ZA200100907B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1899297B1 (en) 2005-07-01 2015-12-09 Generics [UK] Limited Zofenopril calcium in polymorph form c
EA012845B1 (ru) * 2005-12-09 2009-12-30 Менарини Интернэшнл Оперейшнс Люксембург С. А. Фармацевтическая композиция, содержащая зофеноприл и hctz, для лечения гипертензии
AU2007266837A1 (en) * 2006-05-26 2007-12-06 Generics [Uk] Limited Zofenopril calcium
GB0715626D0 (en) * 2007-08-10 2007-09-19 Generics Uk Ltd Crystalline form of zofenopril calcium
CN101981004B (zh) * 2008-02-27 2014-09-17 基因里克斯(英国)有限公司 晶体形式
US8853421B2 (en) 2008-02-27 2014-10-07 Generics [Uk] Limited Crystalline forms of zofenopril calcium
WO2010084515A2 (en) * 2009-01-23 2010-07-29 Glenmark Generics Limited A process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof
SI23949A (sl) 2011-12-19 2013-06-28 Silverstone Pharma Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji
CN104138359B (zh) * 2013-05-06 2016-03-02 扬子江药业集团上海海尼药业有限公司 佐芬普利钙片的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4154935A (en) * 1978-02-21 1979-05-15 E. R. Squibb & Sons, Inc. Halogen substituted mercaptoacylamino acids
US4316906A (en) 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines

Also Published As

Publication number Publication date
CN1316992A (zh) 2001-10-10
HRP20010083A2 (en) 2002-02-28
BG65022B1 (bg) 2006-12-29
NO319773B1 (no) 2005-09-12
DE69917282D1 (de) 2004-06-17
PL345814A1 (en) 2002-01-14
ITMI981833A0 (it) 1998-08-04
IL141222A0 (en) 2002-03-10
HUP0103826A2 (hu) 2002-02-28
DK1102745T3 (da) 2004-08-02
EP1102745A1 (en) 2001-05-30
HK1039616A1 (en) 2002-05-03
AU5372299A (en) 2000-02-28
PT1102745E (pt) 2004-08-31
HRP20010083B1 (en) 2005-02-28
WO2000007984A1 (en) 2000-02-17
IT1301993B1 (it) 2000-07-20
ITMI981833A1 (it) 2000-02-04
EE04798B1 (et) 2007-04-16
SI1102745T1 (en) 2004-10-31
EE200100065A (et) 2002-06-17
YU7501A (sh) 2005-06-10
EA003454B1 (ru) 2003-06-26
US20020156293A1 (en) 2002-10-24
UA65628C2 (uk) 2004-04-15
CA2339283A1 (en) 2000-02-17
EA200100095A1 (ru) 2001-08-27
NO20010552D0 (no) 2001-02-01
BR9912842A (pt) 2001-10-16
BG105176A (en) 2001-11-30
ZA200100907B (en) 2001-10-04
EP1102745B1 (en) 2004-05-12
HU227557B1 (en) 2011-08-29
KR20010072171A (ko) 2001-07-31
US6515012B2 (en) 2003-02-04
ES2221417T3 (es) 2004-12-16
CU23171A3 (es) 2006-09-22
HK1039616B (zh) 2004-10-08
ATE266635T1 (de) 2004-05-15
HUP0103826A3 (en) 2002-03-28
RS49768B (sr) 2008-06-05
PL193828B1 (pl) 2007-03-30
SK1632001A3 (en) 2001-09-11
JP2002522417A (ja) 2002-07-23
DE69917282T2 (de) 2005-05-25
CZ2001408A3 (cs) 2001-07-11
CN1146538C (zh) 2004-04-21
US6521760B1 (en) 2003-02-18
KR100593428B1 (ko) 2006-06-28
TR200100272T2 (tr) 2001-05-21
SK285527B6 (sk) 2007-03-01
CZ301908B6 (cs) 2010-07-28
CA2339283C (en) 2009-03-17

Similar Documents

Publication Publication Date Title
BR0308385A (pt) Cristais de ácido (met) acrìlico e processo para produzir e purificar ácido (met) acrìlico aquoso
CA2473900A1 (en) A process for recovery of low sodium salt from bittern
NO20010552L (no) FremgangsmÕte for fremstilling av zofenopril kalsiumsalt
GB2437006A (en) Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture
CA2425615A1 (en) Process for the purification of gabapentin using a strong cation exchange resin
MA29690B1 (fr) Procede de preparation de la 4beta-amino-4'-demethyl-4-desoxypodophyllotoxine
DK1113990T3 (da) Fremgangsmåde til fremstilling af miljøvenlige krystaller af natriumchlorid
KR970001305A (ko) 발린 정제 방법
HRP20020887B1 (en) Method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril
EA200501734A1 (ru) Способ получения (4-гидрокси-6-оксотетрагидропиран-2-ил)ацетонитрила и его производных
AU8182701A (en) Method for producing 5-aminosalicyclic acid
HRP20000749B1 (en) Purification of carboxaldehyde
WO2004087939A8 (en) A process for the preparation of fludarabine phosphate from 2-fluoroadenine and fludarabine phosphate salts with amines or ammonia
HUP0200187A2 (hu) Eljárás 1,4,7,10-tetraazaciklododekán előállítására
DK1417324T3 (da) Fremgangsmåde til fremstilling af 2-keto-L-gulonsyre
DE50001372D1 (de) Verfahren zur Reinigung von Kreatin
KR960004365A (ko) 5'-리보뉴클레오티드칼슘의 제조방법
JPS5383994A (en) Production of neutral anhydrous sodium sulfate
FR2791682B1 (fr) Procede de preparation du 4'-demethyl-4'-phosphate-2", 3"-bis pentafluorophenoxyacetyl-4",6"-ethyldidene-beta-d- glucoside d'epipodophyllotoxine, et de ses sels
WO2007016209A3 (en) Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process
TH31343B (th) รูปแบบใหม่ของเกลืออินทรีย์ของเอ็น เอ็น-ไดอะเซทิลซิสทีน
RU93009970A (ru) Натриевая соль карбоната таурина, обладающая гипотензивной активностью
TH31343A (th) รูปแบบใหม่ของเกลืออินทรีย์ของเอ็น' เอ็น-ไดอะเซทิลซิสทีน

Legal Events

Date Code Title Description
MK1K Patent expired